{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:14Z","timestamp":1740107714482,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10067-021-05811-7","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:02:49Z","timestamp":1623409369000},"page":"4493-4500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"40","author":[{"given":"Se Rim","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2167-9393","authenticated-orcid":false,"given":"Jin Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"issue":"1","key":"5811_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr et al (2016) 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68(1):1\u201326","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"5811_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landewe RBM, Bijlsma JWJ et al (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79(6):685\u2013699","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"5811_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, van der Heijde D (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68(7):1100\u20131104","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5811_CR4","first-page":"1017","volume":"27","author":"K Visser","year":"2009","unstructured":"Visser K, van der Heijde DM (2009) Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol 27(6):1017\u20131025","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"5811_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/ard.62.5.423","volume":"62","author":"M Hoekstra","year":"2003","unstructured":"Hoekstra M, van Ede AE, Haagsma CJ et al (2003) Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis. Ann Rheum Dis 62(5):423\u2013426","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5811_CR6","first-page":"1727","volume":"31","author":"PD Kent","year":"2004","unstructured":"Kent PD, Luthra HS, Michet C Jr (2004) Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis. J Rheumatol 31(9):1727\u20131731","journal-title":"J Rheumatol"},{"issue":"2","key":"5811_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/anr.1780320202","volume":"32","author":"JM Kremer","year":"1989","unstructured":"Kremer JM, Lee RG, Tolman KG (1989) Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum 32(2):121\u2013127","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5811_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/ard.2008.101378","volume":"69","author":"JR Curtis","year":"2010","unstructured":"Curtis JR, Beukelman T, Onofrei A et al (2010) Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and\/or leflunomide. Ann Rheum Dis 69(1):43\u201347","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5811_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jbspin.2006.01.007","volume":"73","author":"S Pavy","year":"2006","unstructured":"Pavy S, Constantin A, Pham T et al (2006) Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 73(4):388\u2013395","journal-title":"Joint Bone Spine"},{"issue":"7","key":"5811_CR10","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"K Visser","year":"2009","unstructured":"Visser K, Katchamart W, Loza E et al (2009) Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 68(7):1086\u20131093","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"5811_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/ard.2008.092668","volume":"68","author":"K Visser","year":"2009","unstructured":"Visser K, van der Heijde D (2009) Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann Rheum Dis 68(7):1094\u20131099","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5811_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14397595.2018.1472358","volume":"29","author":"H Kameda","year":"2019","unstructured":"Kameda H, Fujii T, Nakajima A et al (2019) Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis. Mod Rheumatol 29(1):31\u201340","journal-title":"Mod Rheumatol"},{"key":"5811_CR13","doi-asserted-by":"crossref","unstructured":"Kim MJ, Shin A, Shin S et al (2019) Treatments patterns among patients with rheumatoid arthritis treated with a biologic disease-modifying anti-rheumatic drug: a nation-wide study in Korea. Arthritis Rheum 71","DOI":"10.1136\/annrheumdis-2019-eular.2777"},{"key":"5811_CR14","doi-asserted-by":"crossref","unstructured":"Westhovens R, Rigby WFC, van der Heijde D et al (2021) Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial. Ann Rheum Dis","DOI":"10.1136\/annrheumdis-2020-219213"},{"issue":"4","key":"5811_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13075-014-0428-x","volume":"16","author":"SH Chang","year":"2014","unstructured":"Chang SH, Park JK, Lee YJ et al (2014) Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study. Arthritis Res Ther 16(4):428","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"5811_CR16","first-page":"895","volume":"33","author":"L Idolazzi","year":"2015","unstructured":"Idolazzi L, Adami S, Capozza R et al (2015) Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study. Clin Exp Rheumatol 33(6):895\u2013899","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"5811_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/1756-185X.12754","volume":"18","author":"CS Lau","year":"2015","unstructured":"Lau CS, Chia F, Harrison A et al (2015) APLAR rheumatoid arthritis treatment recommendations. Int J Rheum Dis 18(7):685\u2013713","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"5811_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1756-185X.2011.01680.x","volume":"15","author":"HY Kim","year":"2012","unstructured":"Kim HY, Hsu PN, Barba M et al (2012) Randomized comparison of etanercept with usual therapy in an Asian population with active rheumatoid arthritis: the APPEAL trial. Int J Rheum Dis 15(2):188\u2013196","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"5811_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00008571-200204000-00002","volume":"12","author":"W Urano","year":"2002","unstructured":"Urano W, Taniguchi A, Yamanaka H et al (2002) Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses. Pharmacogenetics 12(3):183\u2013190","journal-title":"Pharmacogenetics"},{"issue":"5","key":"5811_CR20","first-page":"593","volume":"11","author":"K Kumagai","year":"2003","unstructured":"Kumagai K, Hiyama K, Oyama T, Maeda H, Kohno N (2003) Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Int J Mol Med 11(5):593\u2013600","journal-title":"Int J Mol Med"},{"issue":"1","key":"5811_CR21","doi-asserted-by":"publisher","first-page":"e000363","DOI":"10.1136\/rmdopen-2016-000363","volume":"3","author":"C Takahashi","year":"2017","unstructured":"Takahashi C, Kaneko Y, Okano Y et al (2017) Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study. RMD Open 3(1):e000363","journal-title":"RMD Open"},{"issue":"1","key":"5811_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/annrheumdis-2015-207511","volume":"75","author":"T Atsumi","year":"2016","unstructured":"Atsumi T, Yamamoto K, Takeuchi T et al (2016) The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Ann Rheum Dis 75(1):75\u201383","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5811_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10067-012-2136-8","volume":"32","author":"L Dirven","year":"2013","unstructured":"Dirven L, Klarenbeek NB, van den Broek M et al (2013) Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy. Clin Rheumatol 32(5):585\u2013590","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5811_CR24","first-page":"1266","volume":"33","author":"SK Kim","year":"2006","unstructured":"Kim SK, Jun JB, El-Sohemy A, Bae SC (2006) Cost-effectiveness analysis of MTHFR polymorphism screening by polymerase chain reaction in Korean patients with rheumatoid arthritis receiving methotrexate. J Rheumatol 33(7):1266\u20131274","journal-title":"J Rheumatol"},{"issue":"6","key":"5811_CR25","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00296-011-1989-5","volume":"32","author":"JY Choe","year":"2012","unstructured":"Choe JY, Lee H, Jung HY et al (2012) Methylenetetrahydrofolate reductase polymorphisms, C677T and A1298C, are associated with methotrexate-related toxicities in Korean patients with rheumatoid arthritis. Rheumatol Int 32(6):1837\u20131842","journal-title":"Rheumatol Int"},{"issue":"6","key":"5811_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ et al (2011) Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 89(6):806\u2013815","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"5811_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semarthrit.2015.05.003","volume":"45","author":"R Conway","year":"2015","unstructured":"Conway R, Low C, Coughlan RJ et al (2015) Risk of liver injury among methotrexate users: a meta-analysis of randomised controlled trials. Semin Arthritis Rheum 45(2):156\u2013162","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"5811_CR28","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/acr.22294","volume":"66","author":"G Schmajuk","year":"2014","unstructured":"Schmajuk G, Miao Y, Yazdany J et al (2014) Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Arthritis Care Res (Hoboken) 66(8):1159\u20131166","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"5811_CR29","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/1756-185X.13576","volume":"22","author":"JK Sundbaum","year":"2019","unstructured":"Sundbaum JK, Eriksson N, Hallberg P et al (2019) Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: a long-term follow-up of predictors, surveillance, and outcome in clinical practice. Int J Rheum Dis 22(7):1226\u20131232","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"5811_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/MAJ.0b013e31818c0134","volume":"337","author":"FF Fountain","year":"2009","unstructured":"Fountain FF, Tolley EA, Jacobs AR, Self TH (2009) Rifampin hepatotoxicity associated with treatment of latent tuberculosis infection. Am J Med Sci 337(5):317\u2013320","journal-title":"Am J Med Sci"},{"issue":"3","key":"5811_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/imj.12979","volume":"46","author":"EL Gray","year":"2016","unstructured":"Gray EL, Goldberg HF (2016) Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection. Intern Med J 46(3):281\u2013287","journal-title":"Intern Med J"},{"issue":"9","key":"5811_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-137-9-200211050-00007","volume":"137","author":"JM Kremer","year":"2002","unstructured":"Kremer JM, Genovese MC, Cannon GW et al (2002) Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate - a randomized, double-blind, placebo-controlled trial. Ann Intern Med 137(9):726\u2013733","journal-title":"Ann Intern Med"},{"issue":"9","key":"5811_CR33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1136\/annrheumdis-2016-210629","volume":"76","author":"JH Humphreys","year":"2017","unstructured":"Humphreys JH, Warner A, Costello R et al (2017) Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate. Ann Rheum Dis 76(9):1509\u20131514","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5811_CR34","doi-asserted-by":"publisher","first-page":"rkaa020","DOI":"10.1093\/rap\/rkaa020","volume":"4","author":"S Mori","year":"2020","unstructured":"Mori S, Arima N, Ito M et al (2020) Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study. Rheumatol Adv Pract 4(2):rkaa020","journal-title":"Rheumatol Adv Pract"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05811-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T13:03:30Z","timestamp":1634389410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05811-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5811"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05811-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the Seoul National University Hospital (IRB No. 1904\u2013009-1023). The study was performed in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Patient consent was waived by the IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}